Silva Pharmaceuticals Limited

SILVAPHL

BD0493SPL001

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
16.2 ^BDT	-2.99%		-2.99%	-25.00%

Apr. 29	Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
Jan. 29	Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Silva Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2023

October 29, 2023 at 11:07 am EDT

The Board of Directors of Silva Pharmaceuticals Limited has recommended 1% Cash Dividend for all shareholders for the year ended June 30, 2023.

Latest news about Silva Pharmaceuticals Limited

Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 28	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 28	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	23-10-29	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-01-29	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-26	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-16	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-01-27	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2020	20-12-01	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-01-28	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2019	19-11-04	CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-04-28	CI
Silva Pharmaceuticals Limited Announces Unaudited Earnings Results for the Quarter and Half Year Ended December 31, 2018	19-01-27	CI
Silva Pharmaceuticals Limited Announces Audited Earnings Results for the Year Ended June 30, 2018	18-10-09	CI
Silva Pharmaceuticals Limited has completed an IPO in the amount of BDT 300 million.	18-08-30	CI
Silva Pharmaceuticals Limited has filed an IPO in the amount of BDT 300 million.	18-06-03	CI

Chart Silva Pharmaceuticals Limited

Duration

Period

More charts

Silva Pharmaceuticals Ltd. is a Bangladesh-based pharmaceuticals company. The Company is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Anti pyretic, Anti-inflammatory Drugs, Anti ulcerants, Antiemetic, Gastroprokinetic, Anti histamine, Anti spasmodic expectorants, Vitamins and Minerals medicines which is selling mainly in local market. The Company produces approximately 187 generic medicines. Its products include tablet, capsule, liquid, and dry syrup. The Companyâs products include Actisal, Alvolex, Atechlor, Ambosil, Cipronil, Esosil, Duet, Esypan, Feosi-Z, Glicasil, Multitonic, Multi Gold, Lirel, Omesil, Metlife, Probac, RT-150, Xinoplex, Valpress, Vistasil M, Vasopin Plus, Zoxanid, and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SILVA PHARMACEUTICALS LIMITED	-25.00%	18.82M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B